Medicare
US News: CT is 3rd best in US for healthcare
Based on surveys of state residents on their priorities for state government and health data, Connecticut is third best among states for healthcare, our highest ranking among categories. Healthcare was equally weighted between access (#3 among states), quality (#21), and public health (#6). The subtopics for each health category are: Access Quality Public health Adults…
Read MoreFrom 2011 to 2022, CT hospital budgets devoted 12% to administration labor and 30% to direct patient care labor
Download the brief Download the data Parsing the latest data from NASHP’s Hospital Cost Tool finds that in 2022, Connecticut’s acute care hospitals averaged almost 32% of their budgets on direct patient care labor and just under 12% on labor costs for administration, which includes management, administration, and payments to their larger health system (called…
Read MoreCT middle of the pack for doctors
Connecticut ranks 29th in a new analysis on the Best and Worst States for Doctors by Wallet Hub. Physicians are seventeen of the twenty highest paid US workers. Connecticut tied for 45th worst for the highest malpractice award payouts. We rank 15th in our Medical Environment, which includes the quality and safety of hospital care,…
Read MoreBook Club: Recoding America – Why Government is Failing in the Digital Age and How We Can Do Better
If you’ve ever muttered under your breath about the inefficiency/waste/frustration/etc of government at all levels, you have to read Recoding America – Why Government is Failing in the Digital Age and How We Can Do Better, by Jennifer Pahlka. I don’t think I’ve ever dogeared as many pages in a book. While the author explores…
Read MoreBristol Health Cares explores advocacy in CT healthcare
A recent episode of Bristol Health Cares features a conversation with Kurt Barwis, President and CEO of Bristol Health and Ellen Andrews, of the CT Health Policy Project. Bristol Health Cares is a wide-ranging program with guests ranging from providers, community leaders, to innovators about navigating healthcare and answering questions. The conversation touched on the…
Read MoreWebinar offers tools to improve prescribing
Download the slides and watch the webinar recording Connecticut, like other states, are struggling to improve appropriate prescribing while lowering costs. In Friday’s webinar, Greg Low, RPh, PhD, offered Mass General’s experience of what works to improve physician prescribing at their ACO. Greg is the Manager for Pharmacy Operations at Mass General Brigham Health Plan.…
Read MoreConnecticut health care coverage continues slow shift from private to public coverage
Download the report The latest numbers from the US Census on US health coverage in 2022 found that, as in the past, most Connecticut residents are covered through an employer-sponsored plan. Publicly-funded Medicare and Medicaid each cover about one in five Connecticut residents. While employer-sponsored coverage has slowly declined since 2008, public programs have grown,…
Read MoreMaking it work: Connecting medical and social care in Waterbury
As healthcare costs skyrocket, policymakers are searching for ways to improve the social drivers of poor health with little success. The problem is that the medical system has all the money, while community services manage on shoestrings, and they don’t connect with each other. Some innovators in Connecticut are doing the work to connect the…
Read MoreCT smoking costs total $4.9 million over a lifetime
A new analysis by Nerd Wallet finds that smokers in Connecticut cost an extra $4.9 million over a lifetime or $102,883 per year on average, the 4th highest rate in the US. Only smokers in New York, the District of Columbia, and Maryland have higher costs. Costs include not only out-of-pocket costs for cigarettes, but…
Read MoreNo evidence to justify price increases for eight of top 10 most costly drugs
ICER’s latest Unsupported Price Increase report from the Institute for Clinical and Economic Review finds that, last year, eight of the ten most costly drugs in the US that raised net prices well over the rate of general inflation, had no new clinical evidence of effectiveness to justify the increases. The increases on just these…
Read More